Intervacc AB (FRA:2E9) Buyback Yield %: 0.00 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2E9 Intervacc AB FRA:2E9
63 GF Score
Price €0.09
GF Value €0.09
! 2 Warning Signs
View Full Analysis

What is Intervacc AB Buyback Yield %?

Intervacc AB FRA:2E9 -4.06% 63 Buyback Yield % is 0.00 as of Jul. 18, 2026. GuruFocus rates FRA:2E9 with a GF Score™ of 63/100 and a GF Value™ of €0.09. The stock has 2 warning signs investors should review. Among 740 Biotechnology companies, Intervacc AB ranks worse than 135135% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Intervacc AB's current buyback yield was 0.00%.

Intervacc AB Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Intervacc AB's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intervacc AB Buyback Yield % Chart

Intervacc AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.41 -20.84 0.00 -178.68

Intervacc AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -67.12 -70.86 -63.57 -71.55 0.00

FRA:2E9 vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Intervacc AB's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intervacc AB Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intervacc AB's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Intervacc AB's Buyback Yield % falls into.


FRA:2E9
63GF Score
Intervacc AB FRA:2E9
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intervacc AB Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Intervacc AB's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 20.705) / 11.587642
=-178.68%

Intervacc AB's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 0) / 8.7588941
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of 0.00 mean?
Intervacc AB (FRA:2E9) has a Buyback Yield % of 0.00 as of Jul. 18, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Intervacc AB and its competitors. According to the industry distribution chart, Intervacc AB ranks #999999 out of 740 companies in the Biotechnology industry.
Is Intervacc AB's Buyback Yield % too high?
Intervacc AB's current Buyback Yield % is 0.00. Based on the distribution chart, Intervacc AB ranks #999999 out of 740 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Intervacc AB has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Intervacc AB's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Intervacc AB ranks #999999 out of 740 companies for Buyback Yield %. This places Intervacc AB in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Intervacc AB and its competitors. Intervacc AB's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intervacc AB stock overvalued right now?
Intervacc AB (FRA:2E9) has a current Buyback Yield % of 0.00. The stock's GF Value™ is €0.09, compared to a current price of €0.09 — trading 0.3% below its estimated fair value. The current Buyback Yield % is 0.00. Intervacc AB's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Intervacc AB (FRA:2E9), the current Buyback Yield % is 0.00 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intervacc AB (FRA:2E9) Overvalued in 2026?

Based on GuruFocus' analysis, Intervacc AB stock appears to be undervalued. The current stock price of €0.09 is trading 0.3% below its estimated GF Value™ of €0.09.

Key valuation signals for FRA:2E9:

  • Buyback Yield %: 0.00
  • GF Value™: €0.09 vs. price of €0.09 (0.3% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the FRA:2E9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intervacc AB Business Description

Other Exchanges IVACC:Sweden
Address Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.
63GF Score

Get the complete analysis for FRA:2E9

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.09
Price
€0.09
GF Value